arrow
Back
K

Koutaro Yokote

chiba university

60H-index
642Paper Count
2.2WCitation Count
Published Papers 256
Publication Date
Baseline HDL Cholesterol and the Anti-VEGF Injection-Sparing Effect of an SGLT2 Inhibitor in Diabetic Macular Oedema: A Post Hoc Analysis of the COMET Trial
err2026-08-28
err0
PREAI
errRyoichi Ishibashi; Masaya Koshizaka; Kiichi Hirayama; Toshiki Sakai; Tomoaki Tatsumi; Yoko Takatsuna; Takayuki Baba; Yoshiro Maezawa; Koutaro Yokote
errShare
errSave
Association of GLP-1 Receptor Agonist Use With Cardiovascular Outcomes and Mortality in Japanese Patients With Type 2 Diabetes: A Real-World Claims Database Study
err2026-08-12
err0
PREAI
errMasaya Koshizaka; Ryoichi Ishibashi; Tomoki Ishikawa; Kazuo Goda; Jumpei Sato; Masaru Kitsuregawa; Koutaro Yokote; Naohiro Mitsutake
errShare
errSave
Ophthalmic Backgrounds Influencing the Efficacy of SGLT2 Inhibitor in Diabetic Macular Oedema: Post-hoc Analysis of the COMET Trial
err2026-05-03
err0
PREAI
errRyoichi Ishibashi; Tomoaki Tatsumi; Masaya Koshizaka; Yoko Takatsuna; Tomomi Kaiho; Yosuke Nakamura; Noriko Asaumi; Kiichi Hirayama; Takayuki Baba; Koutaro Yokote
errShare
errSave
Efficacy for LDL-C–lowering and Safety of Pemafibrate Extended-release Formulation in Patients with Statin-intolerant Hypercholesterolemia: A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group trial
err2026-01-22
err0
errOAAI
errShizuya Yamashita; Eiichi Araki; Hidenori Arai; Koutaro Yokote; Ryohei Tanigawa; Keisuke Kunitomi; Kaho Ikegami; Hideki Suganami; Masaya Tanahashi; Sara Minamikawa; Shun Ishibashi
errShare
errSave
Hypoxia, iron, and ferroptosis: a novel perspective on pheochromocytoma progression and therapy
err2025-12-01
err0
PREAI
errRuike, Yutaro; Suzuki, Sawako; Hashimoto, Rei; Sugo, Masafumi; Watanabe, Suzuka; Igarashi, Katsushi; Ishiwata, Kazuki; Naito, Kumiko; Ishida, Akiko; Fujimoto, Masanori; Koide, Hisashi; Imamura, Yusuke; Sakamoto, Shinichi; Ichikawa, Tomohiko; Takahashi, Kohei; Ozawa, Yoshihito; Ikeda, Jun-ichiro; Yokote, Koutaro
errShare
errSave
Efficacy and safety of SGLT2 inhibitor on insulin resistance and hyperglycemia in Werner syndrome-A case report
err2025-11-01
err0
errOAAI
errYagi, Takashi; Aotani, Daisuke; Hasegawa, Chie; Shimizu, Yuki; Koyama, Hiroyuki; Maezawa, Yoshiro; Yokote, Koutaro; Tanaka, Tomohiro
errShare
errSave
PS13.4: Autologous transplantation of LCAT gene-transduced adipocytes enabled long-term LCAT replacement in a patient with LCAT deficiency in first in human clinical trial.
err2025-10-20
err0
PREAI
errKuroda, Masayuki; Wada, Jun; Masezawa, Yoshiro; Kubota, Yoshitaka; Mitsukawa, Nobuyuki; Yasunaga, Kunio; Yamamoto, Tokuo; Aso, Masayuki; Hanaoka, Hideki; Saito, Yasushi; Yokote, Koutaro
errShare
errSave
Redox-dependent liver gluconeogenesis impacts different intensity exercise in mice
err2025-09-18
err0
errOAAI
errTakahiro Horiuchi; Keizo Kaneko; Shinichiro Hosaka; Kenji Uno; Seitaro Tomiyama; Kei Takahashi; Maya Yamato; Akira Endo; Hiroto Sugawara; Yohei Kawana; Yoichiro Asai; Shinjiro Kodama; Junta Imai; Seiya Mizuno; Satoru Takahashi; Atsushi Takasaki; Hiraku Ono; Koutaro Yokote; Rae Maeda; Yuki Sugiura; Hideki Katagiri
errShare
errSave
A Case of Acquired LCAT Deficiency with the Discrepancy between Spontaneous Resolution of Proteinuria and Continually Low HDL Cholesterol Levels
err2025-09-01
err0
errOAAI
errMatsuo, Miki; Ogura, Masatsune; Kuroda, Masayuki; Arisato, Tetsuya; Kishida, Masatsugu; Harada-Shiba, Mariko; Wada, Jun; Yokote, Koutaro; Yoshihara, Fumiki
errShare
errSave
Sodium-glucose co-transporter 2 inhibitors reduce the intravitreal anti-VEGF treatment necessity in eyes with early diabetic macular oedema: A post-hoc analysis focusing on the fellow eye of the COMET trial
err2025-08-04
err0
PREAI
errTomoaki Tatsumi PhD; Yoko Takatsuna PhD; Ryoichi Ishibashi PhD; Masaya Koshizaka PhD; Tomomi Kaiho PhD; Toshiyuki Oshitari PhD; Yuki Shiko PhD; Noriko Asaumi MD; Shuichi Yamamoto PhD; Koutaro Yokote PhD; Takayuki Baba PhD
errShare
errSave
Regulation of H3K4me3 breadth and MYC expression by the SETD1B catalytic domain in MLL-rearranged leukemia
errLEUKEMIA
IF13.4
err2025-05-08
err0
errOAAI
errIzumi, Shintaro; Ohtani, Ko; Matsumoto, Makoto; Shibata, Seito; Rahmutulla, Bahityar; Fukuyo, Masaki; Nishimoto, Mitsutaka; Miyagawa, Hideo; Sakaida, Emiko; Yokote, Koutaro; Kitabayashi, Issay; Araki, Kimi; Kaneda, Atsushi; Hoshii, Takayuki
errShare
errSave
Ranibizumab with luseogliflozin in type 2 diabetes with diabetic macular oedema: A randomised clinical trial
err2025-02-11
err0
errOAAI
errIshibashi, Ryoichi; Takatsuna, Yoko; Koshizaka, Masaya; Tatsumi, Tomoaki; Takahashi, Sho; Nagashima, Kengo; Ishikawa, Ko; Kaiho, Tomomi; Asaumi, Noriko; Baba, Takayuki; Yamamoto, Shuichi; Yokote, Koutaro; COMET Trial investigators
errShare
errSave
Pharmacokinetics and Safety of Pemafibrate in Patients with both Dyslipidemia and Severe Renal Impairment: A Phase 4 Study
err2025-02-01
err0
errOAAI
errIshibashi, Shun; Arai, Hidenori; Yokote, Koutaro; Araki, Eiichi; Watanabe, Mao; Nakanishi, Michiko; Makinose, Yuichi; Suganami, Hideki; Kurihara, Yuji; Yamashita, Shizuya
errShare
errSave
Shifting paradigms in primary aldosteronism: reconsideration of screening strategy via integrating pathophysiological insights
err2025-01-14
err0
errOAAI
errKitamoto, Takumi; Ruike, Yutaro; Koide, Hisashi; Inoue, Kosuke; Maezawa, Yoshiro; Omura, Masao; Nakai, Kazuki; Tsurutani, Yuya; Saito, Jun; Kuwa, Katsuhiko; Yokote, Koutaro; Nishikawa, Tetsuo
errShare
errSave
Effects of the SGLT2 inhibitor ipragliflozin and metformin on hepatic steatosis and liver fibrosis: Sub-analysis of a randomized controlled study
err2025-01-13
err0
PREAI
errHirayama, Kiichi; Koshizaka, Masaya; Ishibashi, Ryoichi; Shoji, Mayumi; Horikoshi, Takuro; Sakurai, Kenichi; Yokote, Koutaro; PRIME V Study Grp
errShare
errSave
Long-Term Effects of Extended-Release Pemafibrate Tablets on Dyslipidemia and Safety in Triglyceridemic Patients: A Phase 3, Multicenter, Randomized, Open-Label, Parallel-Group Study
err2025-01-01
err0
errOAAI
errArai, Hidenori; Yamashita, Shizuya; Araki, Eiichi; Yokote, Koutaro; Tanigawa, Ryohei; Saito, Ayumi; Furukawa, Daisuke; Suganami, Hideki; Ishibashi, Shun
errShare
errSave
errShare
errSave
Efficacy and Safety of Pemafibrate Extended-Release Tablet: a Phase 3, Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group Comparison Trial
err2024-11-01
err4
errOAAI
errArai, Hidenori; Yamashita, Shizuya; Araki, Eiichi; Yokote, Koutaro; Tanigawa, Ryohei; Saito, Ayumi; Yamasaki, Sayumi; Suganami, Hideki; Ishibashi, Shun
errShare
errSave